Series C Convertible Preferred Stock Purchase Agreement Sample Contracts

Collegium Pharmaceutical – Amendment No. 1 to Series C Convertible Preferred Stock Purchase Agreement (April 2nd, 2015)

This Amendment No. 1 (this Amendment) dated as of September 24, 2013 amends that certain Series C Convertible Preferred Stock Purchase Agreement dated as of August 27, 2013 (the Purchase Agreement) by and among Collegium Pharmaceutical, Inc., a Delaware corporation (the Company), and the persons and entities listed on Schedule A attached thereto (the Purchasers). All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Purchase Agreement.

Collegium Pharmaceutical – COLLEGIUM PHARMACEUTICAL, INC. Series C Convertible Preferred Stock Purchase Agreement Dated as of August 27, 2013 (April 2nd, 2015)

This Series C Convertible Preferred Stock Purchase Agreement (Agreement) dated as of August 27, 2013 is entered into by and among Collegium Pharmaceutical, Inc., a Delaware corporation (the Company), the individuals and entities listed on Schedule A hereto together with any individuals and entities who become parties to this Agreement by executing and delivering a financing signature page in the form of Schedule B hereto (each a Purchaser and collectively, the Purchasers). In consideration of the mutual promises and covenants contained in this Agreement, the parties hereto agree as follows:

Collegium Pharmaceutical – Amendment No. 1 to Series C Convertible Preferred Stock Purchase Agreement (March 3rd, 2015)

This Amendment No. 1 (this Amendment) dated as of September 24, 2013 amends that certain Series C Convertible Preferred Stock Purchase Agreement dated as of August 27, 2013 (the Purchase Agreement) by and among Collegium Pharmaceutical, Inc., a Delaware corporation (the Company), and the persons and entities listed on Schedule A attached thereto (the Purchasers). All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Purchase Agreement.

Intercept Pharmaceuticals, Inc. Series C Convertible Preferred Stock Purchase Agreement (September 4th, 2012)

This Agreement dated as of August 9, 2012 is entered into by and among INTERCEPT PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), and the investors listed on Schedule A attached hereto (each a "Purchaser" and collectively the "Purchasers"). The Company and the Purchasers hereafter may be referred to individually as a "Party" and collectively as the "Parties".

Exa Corporation – Exa Corporation Series C Convertible Preferred Stock Purchase Agreement (August 3rd, 2011)

This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the Agreement) is made this 30th day of September, 1996 by and among Exa Corporation, a Massachusetts corporation (the Company) and Fidelity Ventures Ltd. (Fidelity), Fidelity Investors Limited Partnership (Fidelity Investors), Boston Capital Ventures III, Limited Partnership (BCV), Edelson Technology Partners (Edelson), Massachusetts Capital Resource Company (MCRC), Associated Group, Inc. (Associated), Itochu Corporation, Itochu Techno-Science Corporation, Itochu Technology, Inc., John J. Shields, III and John William Poduska (collectively, the Investors).

Vycor Medical Inc – SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Dated as of June ___, 2011 Among VYCOR MEDICAL, INC. And THE PURCHASERS LISTED ON EXHIBIT A (June 9th, 2011)

This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the Agreement) is dated as of June [__], 2011 by and among Vycor Medical, Inc., a Delaware corporation (the Company), and each of the Purchasers of shares of Series C Convertible Preferred Stock of the Company whose names are set forth on Exhibit A hereto (individually, a Purchaser and collectively, the Purchasers).

CURAXIS PHARMACEUTICAL Corp – Series C Convertible Preferred Stock Purchase Agreement (May 12th, 2011)

This Series C Convertible Preferred Stock Purchase Agreement, dated as of the 30th day of March, 2011 (this "Agreement"), by and between Curaxis Pharmaceutical Corporation, a Nevada corporation (the "Company") and C P Acquisition Partners LP (the "Purchaser"). The Company and the Purchaser are individually referred to herein as a "Party" and collectively, as the "Parties."

Ocean Smart, Inc. – SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Dated as of November 5, 2007 Among EDGEWATER FOODS INTERNATIONAL, INC. And THE PURCHASERS LISTED ON EXHIBIT A (November 7th, 2007)
Avicena Group – Series C Convertible Preferred Stock Purchase Agreement (September 28th, 2007)

This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the Agreement) is dated as of September 24, 2007 by and among Avicena Group, Inc., a Delaware corporation (the Company), and each of the Purchasers of shares of Series C Convertible Preferred Stock of the Company whose names are set forth on Exhibit A hereto (individually, a Purchaser and collectively, the Purchasers).

Sentō – Sento Corporation Series C Convertible Preferred Stock Purchase Agreement (August 22nd, 2007)

This Series C Convertible Preferred Stock Purchase Agreement (the "Agreement") is entered into as of August 17, 2007, by and among Sento Corporation, a Utah corporation (the "Company") and each of those persons and entities, severally and not jointly, whose names are set forth on the Schedule of Purchasers attached hereto as Exhibit A (which persons and entities are hereinafter collectively referred to as "Purchasers" and each individually as a "Purchaser").

Clearstory Systems – Contract (February 3rd, 2005)

SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT is made as of the 28th day of January, 2005, by and among CLEARSTORY SYSTEMS, INC. (f/k/a INSCI Corp.), a Delaware corporation (the "Company"), SCP II PRIVATE EQUITY PARTNERS II, L.P., a Delaware limited partnership ("SCP"), CIP Capital L.P., a Delaware limited partnership ("CIP") and CSSMK, LLC, a Massachusetts limited liability company ("CSSMK", and with SCP and CIP, the "Investors"). In consideration of the mutual promises hereinafter set forth, the parties hereto, each intending to be legally bound hereby, agree as follows: 1. PURCHASE AND SALE. 1.1 SALE AND ISSUANCE OF SERIES C CONVERTIBLE PREFERRED STOCK. Subject to the terms and conditions of this Agreement, each Investor agrees to purchase, and the Company agrees to sell and issue to such Investor, that number of shares of the Company's Series C Convertible Preferred Stock, par v

Digital Video Systems, Inc. 8% Series C Convertible Preferred Stock Purchase Agreement (September 24th, 2004)

THIS 8% SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is entered into as of September 20, 2004, by and among DIGITAL VIDEO SYSTEMS, INC., a Delaware corporation (the "Company") and each of those persons and entities whose names are set forth on the Schedule of Purchasers attached hereto as Exhibit A, as the same may be amended by the Company from time to pursuant to the terms hereof (which persons and entities are hereinafter sometimes collectively referred to as "Purchasers" and each individually sometimes as a "Purchaser").

Regen Biologics – Regen Biologics, Inc. Series C Convertible Preferred Stock Purchase Agreement (October 6th, 2003)

This Agreement, dated as of September 30, 2003, is entered into by and among ReGen Biologics, Inc., a Delaware corporation (the Company), and the individuals and entities listed on Exhibit A hereto (each a Purchaser and collectively, the Purchasers).

Regen Biologics – Regen Biologics, Inc. Series C Convertible Preferred Stock Purchase Agreement (September 25th, 2003)

This Agreement, dated as of September 23, 2003, is entered into by and among ReGen Biologics, Inc., a Delaware corporation (the Company), and the individuals and entities listed on Exhibit A hereto (each a Purchaser and collectively, the Purchasers).

Clearstory Systems – Contract (September 19th, 2003)

EXHIBIT 10.76 SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT is made as of the 4th day of September, 2003, by and among INSCI Corp., a Delaware corporation (the "Company") and SCP Private Equity Partners II, L.P., a Delaware limited partnership (the "Investor"). IN CONSIDERATION OF THE MUTUAL PROMISES HEREINAFTER SET FORTH, THE PARTIES HERETO, EACH INTENDING TO BE LEGALLY BOUND HEREBY, AGREE AS FOLLOWS: 1. PURCHASE AND SALE. 1.1 SALE AND ISSUANCE OF SERIES C CONVERTIBLE PREFERRED STOCK. (a) The Company shall adopt and file with the Secretary of State of Delaware, on or before the Closing (as defined below), a Certificate of Designation in the form attached hereto as Exhibit A (the "Designation"). (b) Subject to the terms and conditions of this Agreement, the Investor agrees to purchase, and the Company agrees t

Audible Inc. – Series C Convertible Preferred Stock Purchase Agreement (August 5th, 2003)

This Series C Convertible Preferred Stock Purchase Agreement (together with the schedules and exhibits hereto, the "Agreement") dated as of August __, 2003, is entered into by and among Audible, Inc., a Delaware corporation (the "Company"), and the persons and individuals, severally but not jointly, identified on Schedule I hereto (each, an "Investor" and collectively, the "Investors").

Computer Motion Inc – Amendment No. 1 to Series C Convertible Preferred Stock Purchase Agreement (December 12th, 2002)

This Amendment No. 1 to Series C Convertible Preferred Stock Purchase Agreement (the "Amendment") is entered into as of December 11, 2002, by and between Computer Motion, Inc., a Delaware corporation (the "Company"), and the persons and entities listed on Exhibit A hereto (each a "Purchaser" and collectively, the "Purchasers").

Soligen Technologies Inc – SOLIGEN TECHNOLOGIES, INC. SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Closing: February 22, 2001 (March 9th, 2001)

THIS SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is made and entered into as of the date written above (the "Effective Date"), by and among Soligen Technologies, Inc., a Wyoming corporation, (the "Company"), and the purchasers listed on Exhibit A attached hereto (the "Schedule of Purchasers"). The persons or entities listed on the Schedule of Purchasers are hereinafter referred to collectively as the "Purchasers" and individually as a "Purchaser".